SELLAS Life Sciences Group, Inc.
USD8.19
-0.14 (-1.68%)
CEO
Angelos Stergiou
IPO Date
2008-03-12
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$8.12
Prev. Close
$8.33
Day Low
$7.85
Day High
$8.28
52W Low
$1.39
52W High
$9.51
Market Cap
$1.17B
Volume
7.44M
| 50,000 |
| $0.00 |
| 9 Jan 2026 | SCHEINBERG DAVID A | director | A-Award | Acquired | 50,000 | $0.00 |
| 9 Jan 2026 | CICIC DRAGAN | SVP, Chief Development Officer | A-Award | Acquired | 300,000 | $0.00 |
| 9 Jan 2026 | Burns John Thomas | CFO | A-Award | Acquired | 300,000 | $0.00 |
| 9 Jan 2026 | Kalin Katherine Bach | director | A-Award | Acquired | 50,000 | $0.00 |
| 9 Jan 2026 | Wasman Jane | director | A-Award | Acquired | 50,000 | $0.00 |
| 5 Dec 2025 | CICIC DRAGAN | SVP, Chief Development Officer | J-Other | Disposed | 63,800 | $1.50 |
| 5 Dec 2025 | Burns John Thomas | CFO | J-Other | Disposed | 58,592 | $1.50 |
| 5 Dec 2025 | Stergiou Angelos M. | director, officer: President and CEO | J-Other | Disposed | 187,066 | $1.50 |